Alexa
  • Directory of Taiwan

FDA chief to detail delays inspecting baby formula plant

WASHINGTON (AP) — Federal plans to inspect a baby formula factory linked to the nationwide shortage were slowed by COVID-19, scheduling conflicts and other logistical problems, according to prepared t...

US safety, savings rules set stage for baby formula shortage

WASHINGTON (AP) — A massive recall is getting most of the blame for the U.S. baby formula shortage, but experts say the products have long been vulnerable to this type of crisis due to decades-old pol...

FDA head: Baby formula factory could reopen by next week

WASHINGTON (AP) — The head of the Food and Drug Administration told lawmakers Thursday that a shuttered baby formula factory could be up and running as soon as next week, though he sidestepped questio...

US allows more baby formula imports to fight shortage

WASHINGTON (AP) — Under fire from parents and politicians, President Joe Biden’s administration announced steps Monday to ease a nationwide shortage of baby formula, including reopening the largest do...

EXPLAINER: What's behind the baby formula shortage?

WASHINGTON (AP) — Many parents are hunting for infant formula because of a combination of short- and long-term problems that has hit most of the biggest U.S. brands. Millions of babi...

Parents hunting for baby formula as shortage spans US

WASHINGTON (AP) — Parents across the U.S. are scrambling to find baby formula because supply disruptions and a massive safety recall have swept many leading brands off store shelves. ...

Rare cases of COVID returning pose questions for Pfizer pill

WASHINGTON (AP) — As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking t...

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The ...

Change at the top for Biogen after Alzheimer's drug flops

Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and in...

Lawmakers scrutinize McKinsey's opioid, FDA consulting work

WASHINGTON (AP) — House Democrats vowed to continue investigating consulting giant McKinsey's work with opioid drugmakers after a Wednesday hearing detailed how the firm had advised companies pushing ...

EXPLAINER: COVID-19 pills must be taken within 5 days

Newly infected COVID-19 patients have two treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear. ...

Plan to ban menthol cigarettes prompts late lobbying blitz

WASHINGTON (AP) — As federal officials finalize a long-awaited plan to ban menthol cigarettes, dozens of interest groups have met with White House staffers to try to influence the process, which has t...

E-cigs using synthetic nicotine come under FDA oversight

WASHINGTON (AP) — U.S. regulators will soon begin cracking down on vaping companies using a now-closed loophole, including a line of fruit-flavored e-cigarettes that have become teenagers' top choice....

Medicare weighs premium cut after limiting Alzheimer's drug

WASHINGTON (AP) — Medicare said Thursday it's considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer's drug project...

US experts wrestle with how to update COVID-19 vaccines

WASHINGTON (AP) — More than two years into the COVID-19 pandemic, U.S. health officials are beginning to grapple with how to keep the vaccines updated to best protect Americans from the ever-changing ...